{{{menujs}}}

Bibliografia   1.Olbe L, et al. “A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole.” Nat Rev Drug Discov. 2003 Feb;2(2):132-9. 2. Omeprazen RCP. 3. Cullen D, et al. “Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anty-inflammatory drug users.” Aliment Pharmacol Ther 1998; 12: 135-140. 4. Condra LJ, et al. “Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy.” Am J Managed Care 1999; 5: 631-638. 5.Mulder, CJJ, et al. “A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.” European Journal of Gastroenterology & Hepatology 2002; 14(6): 649-56. 6. 19th edition (April 2015) - Rev. November 2015. http://www.who.int/medicines/publications/essentialmedicines/en/index.html 7. Li W. et al. “Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management.” Therapeutics and Clinical Risk Management 2013; 9: 259-71. 8. Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/?term=”Omeprazole.